BackWelgene Biotech ,Ltd. Overview

Welgene Biotech ,Ltd. Common Stock

Latest common stock for 6661.TWO: $230M.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$233.04M
↑ 0.00% YoYΔ $0.00 vs prior year quarter

Peer trimmed avg / median

Loading

Welgene Biotech ,Ltd. Common Stock History

Loading

Welgene Biotech ,Ltd. vs. peers: Common Stock Comparison

Loading

Welgene Biotech ,Ltd. Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Welgene Biotech ,Ltd. (6661.TWO) FAQ

As of the most recent data (June 2026), 6661.TWO shows a common stock of $230M. That compares with $230M in the prior-year period — up 0.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6661.TWO's common stock is now $230M (was $230M) — essentially flat versus a year earlier. Pairing that YoY change with peer averages gives a clearer picture of whether Welgene Biotech ,Ltd. is outperforming or lagging.

Tracking 6661.TWO's common stock over time shows whether Welgene Biotech ,Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $230M That compares with $230M in the prior-year period — up 0.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Welgene Biotech ,Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $230M) with ownership activity and broader fundamentals.